ArticleBMC medicine2025
Prevalence of hysterectomy in urban China and associations between metabolic disorders and hysterectomy: a multicenter population-based study involving over 9 million women.
Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The impact of a symptomics-based transitional care program on mental health and quality of life in perimenopausal women after total hysterectomy: A retrospective study.Pakistan journal of medical sciences · 2026Article
- Changes in Hospitalization Expenditures and Length of Stay for Patients Underwent Hysterectomy and Adnexectomy for Carcinoma in situ and Nonmalignant Lesions Diagnosis-Related Group: Impact of Beijing's Medicine-Consumables Linkage Reforms.Risk management and healthcare policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundHysterectomy prevalence varies from 4 to 41% across populations, but the rates in China and the risk factors remain unclear. The study aimed to estimate the prevalence of hysterectomy in Chinese and explore the potential risk factors.
methodsA multicenter cross-sectional study was conducted with Meinian health screening center chain across 31 provinces of China between January 2017 and December 2018. Data from 9,013,462 participants aged ≥ 18 years were extracted for the current study. The geographic variation of hysterectomy prevalence was illustrated with different colors on the national map of China. Relative risk (RR) and 95% confidence intervals (CIs) from log-binomial regression were used to estimate the associations between hysterectomy and metabolic disorders.
resultsThe age-standardized prevalence of hysterectomy in China was 2.36% (95% CIs, 2.35-2.37), with the highest in the Jiangsu Province (3.26%) and Northeast region (2.67%). Women aged 55-59 years had the highest prevalence of hysterectomy (7.61%). Hysterectomy was positively associated with obesity [RR, 1.31 (95% CIs, 1.29-1.32)]; hypertension [1.22 (1.21-1.23)]; diabetes [1.26 (1.24-1.28)]; hyperglycemia [1.22 (1.20-1.23)]; dyslipidemia [1.18 (1.16-1.19)]; metabolic associated fatty liver disease [1.25 (1.24-1.26)]; and metabolic syndrome [1.18 (1.16-1.21)]. In the 18-34 years age group, the positive associations of hysterectomy with diabetes and hypertension were 6.09 (4.48-8.26) and 6.08 (5.18-7.14).
conclusionsIn this large-scale study, the prevalence of hysterectomy was higher among menopausal women or those living in the East and Northeast regions. Hysterectomy was strongly associated with metabolic disorders, especially in women of childbearing age. Further studies were warranted to elucidate the underlying mechanisms and develop public health policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.